Targeted treatment to reduce asthma prevalence and the impact of severe asthma

有针对性的治疗可减少哮喘患病率和严重哮喘的影响

• 批准号: nhmrc : GNT1155810
• 负责人: Prof Peter Gibson
• 金额: $ 58.53万
• 依托单位国家: 澳大利亚
• 项目类别: Practitioner Fellowships
• 财政年份: 2019
• 资助国家: 澳大利亚
• 起止时间: 2019-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/targeted-treatment-reduce-severe-asthma/1349197
• 关键词: Targeted; treatment; reduce; asthma; prevalence

Asthma remains a significant problem because it is common, and because of the burden of severe asthma. This research will address asthma prevalence in childhood by targeting asthma therapy in pregnancy to reduce childhood asthma. New targeted therapies in severe asthma will be assessed and their optimum use defined.

哮喘仍然是一个重要的问题，因为它是常见的，因为严重哮喘的负担。这项研究将通过针对怀孕期间的哮喘治疗来减少儿童哮喘，从而解决儿童哮喘的患病率。将评估严重哮喘的新靶向疗法，并确定其最佳用途。